Page 11 - Morphosys This News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys this. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys This Today - Breaking & Trending Today

MorphoSys (NASDAQ:MOR) Sees Strong Trading Volume

MorphoSys AG (NASDAQ:MOR – Get Free Report) saw strong trading volume on Thursday . 228,599 shares were traded during trading, an increase of 43% from the previous session’s volume of 159,644 shares.The stock last traded at $7.19 and had previously closed at $8.01. Analysts Set New Price Targets A number of equities research analysts recently […] ....

United States , T Rowe Price Investment Management Inc , Optiver Holding , Wells Fargo Company , Jpmorgan Chase Co , Deutsche Bank Aktiengesellschaft , Td Asset Management Inc , Morphosys Company Profile , Opaleye Management Inc , Get Free Report , Rowe Price Investment Management , Global Management , Management Inc , Morphosys Daily , Nasdaq Mor ,

Deutsche Bank Aktiengesellschaft Upgrades MorphoSys (NASDAQ:MOR) to "Hold"

MorphoSys (NASDAQ:MOR – Get Free Report) was upgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a “sell” rating to a “hold” rating in a note issued to investors on Monday, MarketBeat Ratings reports. Several other equities research analysts have also recently weighed in on MOR. UBS Group assumed coverage on shares of MorphoSys […] ....

United States , Optiver Holding , Jpmorgan Chase Co , Deutsche Bank Aktiengesellschaft , Td Asset Management Inc , Opaleye Management Inc , Wells Fargo Company , T Rowe Price Investment Management Inc , Get Free Report , Marketbeat Ratings , Wells Fargo , Rowe Price Investment Management , Global Management , Management Inc , Morphosys Daily , Nasdaq Mor ,

MorphoSys (NASDAQ:MOR) Upgraded by JPMorgan Chase & Co. to "Overweight"

JPMorgan Chase & Co. upgraded shares of MorphoSys (NASDAQ:MOR – Get Rating) from an underweight rating to an overweight rating in a research report report published on Friday morning, The Fly reports. JPMorgan Chase & Co. currently has $10.00 target price on the stock, up from their prior target price of $3.30. Separately, UBS Group […] ....

Sigma Securities , Optiver Holding , T Rowe Price Investment Management Inc , Susquehanna International Group , Jpmorgan Chase Co , Get Rating , Global Management , Rowe Price Investment Management , Morphosys Daily , Nasdaq Mor , Jpmorgan Chase Co ,

MorphoSys (NASDAQ:MOR) Receives New Coverage from Analysts at Wells Fargo & Company

Wells Fargo & Company began coverage on shares of MorphoSys (NASDAQ:MOR – Get Rating) in a research note released on Friday morning, The Fly reports. The firm issued an overweight rating and a $17.00 target price on the stock. A number of other equities analysts have also commented on the company. UBS Group assumed coverage […] ....

Jpmorgan Chase Co , Wells Fargo Company , Citadel Advisors , Susquehanna International Group , Sigma Securities , Virtu Financial , Wells Fargo , Get Rating , International Group , Two Sigma Securities , Morphosys Daily , Nasdaq Mor , Initiated Coverage ,